Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)

Leukemia. 2020 May;34(5):1458-1461. doi: 10.1038/s41375-019-0658-7. Epub 2019 Dec 11.

¹ Department of Clinical Haematology, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK. [email protected].
² Department of Clinical Hematology and Unité Mixte de Recherche-Centre National de la Recherche Scientifique 5235, Centre Hospitalier Universitaire, Université de Montpellier, Montpellier, France.
³ Cardiff Chronic Lymphocytic Leukemia Research Group, School of Medicine, Cardiff University, Cardiff, UK.
⁴ EA 7365 Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University of Lille, Lille, France.
⁵ Department of Hematology, Centre Hospitalier Régional Universitaire, Lille, France.
⁶ Gilead Sciences, Inc, Foster City, CA, USA.
⁷ Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Hématologie, Pierre-Bénite Université de Lyon, Lyon, France.
⁸ Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, UK.

No abstract available

Publication types